SIMPONI GOLIMUMAB 100MG INJECTION 0.4ML

Simponi (golimumab) is a monoclonal antibody used primarily for the treatment of autoimmune conditions. It is indicated for adults with moderate to severe rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. Additionally, Simponi is used in the management of ulcerative colitis and Crohn’s disease.

The drug works by inhibiting tumor necrosis factor-alpha (TNF-alpha), a substance in the body that causes inflammation. By blocking TNF-alpha, Simponi helps reduce inflammation, pain, and damage to joints and tissues associated with these conditions.

Simponi is administered via subcutaneous injection, typically starting with an initial dose followed by maintenance doses. It is important for patients to be monitored for potential side effects, including increased risk of infections. Overall, Simponi provides significant relief and improved quality of life for individuals suffering from chronic inflammatory diseases.